Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Accelovance

Accelovance
2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
5 INVESTMENTS
Description

Provider of clinical development contract research services intended to improve the quality and predictability in clinical research. The company's researches are focused on vaccine, oncology, dermatology, nutrition and women's health, enabling pharmaceutical companies, biotechs, CROs, and academic institutions to leverage operational knowledge and patient recruitment strategies in successful clinical trials.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Acquirer
Primary Office
  • 2275 Research Boulevard
  • Suite 700
  • Rockville, MD 20850
  • United States

+1 (240) 000-0000

Accelovance Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Accelovance‘s full profile, request access.

Request full access to PitchBook

Accelovance Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pharm-Olam International Private Equity-Backed Houston, TX 00000 0000000 0000 00000
000 00000000 Corporation Burlingame, CA
00000 0000000 Corporation Dickinson, ND 00
0000 0000000000 00 Corporate Backed or Acquired Hinckley, OH 000 000000&0
000000000 00000000 Private Equity-Backed Morrisville, NC 000 00000 000000000000 00000
To view this company’s complete list of competitors, request access »

Accelovance Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 26-May-2016 000000000000000000 Drug Discovery 0000000 00000000
000000000 00000 02-Dec-2015 000000000000000000 Discovery Tools (Healthcare) 0000000 00000000
000000 00000000 05-Feb-2015 000000000000000000 Other Healthcare Services 0000000 00000000
0000000 0000000000 06-Mar-2013 000000000000000000 Practice Management (Healthcare) 0000000 00000000
nTouch Research 01-Feb-2005 Merger/Acquisition Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Accelovance Subsidiaries (1)

Company Name Industry Location Founded
000000000 00000 Discovery Tools (Healthcare) Amsterdam, Netherlands 0000
To view this company’s complete subsidiary history, request access »

Accelovance Executive Team (9)

Name Title Board
Seat
Contact
Info
Stephen Trevisan Co-Founder, Chief Executive Officer & President
Vita Lanoce Chief Executive Officer, Linical Accelovance
Joseph Angle Jr. Chief Financial Officer & Co-Founder
Jamie Oliver Chief Science Officer
John Naples Finance Director

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

Accelovance Board Members (1)

Name Representing Role Since Contact
Info
00000000 000000 00.0 Self Chairman, Clinical and Scientific Advisory Board 000 0000